American Academy of Nursing Announces 2021 Election Results

President-Elect, Treasurer, Board of Directors, and Committee Members will Assume Leadership Positions

The American Academy of Nursing (Academy) announces its election results for President-Elect, Treasurer, Board of Directors, Fellow Selection Committee, and Nominating Committee.

“The Academy is pleased to announce the Fellows, elected by their peers, who will be assuming leadership positions within the organization following the conclusion of this year’s hybrid Health Policy Conference,” said Academy President Eileen Sullivan-Marx, PhD, RN, FAAN. “During my term as President, I have been inspired by the work of Academy Fellows to keep their communities safe and promote public health. I have seen first-hand the passion that drives our Fellows, the collective expertise our organization possesses, and the impact our voice makes on the health of those we serve. I know each of these exceptional leaders will be dedicated to advancing the organization’s vision, mission, and strategy so that we can continue to improve health and achieve health equity.”

Linda D. Scott, PhD, RN, NEA-BC, FNAP, FAAN, Dean and Professor, University of Wisconsin Madison School of Nursing, will assume the role of President-Elect. Inducted into the Academy in 2008, Dr. Scott previously served two terms on the Academy’s Board of Directors from 2015-2019 and is actively involved in the Fellow Selection Review Steering Committee, having previously served as Chair of the Fellow Selection Committee in 2014. While her research focuses on the impact of fatigue and sleep deprivation, she has been a staunch advocate for economically disadvantaged students throughout her career. Dr. Scott leads diversity efforts across the University of Wisconsin Madison campus, including implementing a holistic admissions process for the School of Nursing.

“I am beyond honored to have been selected as President-Elect by my peers,” said Dr. Scott. “As we continue to respond to a global pandemic and social injustice, I look forward to collaborating with Academy Fellows to advance health policy, research, and practice that maximize equity, diversity, and inclusivity in our efforts toward the Academy’s vision of healthy lives for all people.”

Kathleen Chavanu Gorman, MSN, RN, FAAN, Executive Vice President, Patient Care Services and Chief Operating Officer, Children’s National Hospital, has been re-elected for a second term as Treasurer. Throughout her first term, despite the challenges associated with the COVID-19 pandemic, Ms. Gorman has overseen financial gains, clean audits, and increases in the Academy’s long-term investment portfolio. Her career has focused on advancing patient safety, quality, and clinical resource management to improve care outcomes and inform policy for children and families. Inducted into the Academy in 2014, Ms. Gorman has also served on the Finance Committee prior to becoming Treasurer.

“I am honored to serve a second term as Treasurer while we continue to ensure the highest standards of financial integrity,” said Ms. Gorman. “Through strong fiscal management of the Academy’s resources we can strategically advance policy efforts to further protect the health and wellbeing of vulnerable populations.”

Versie Johnson-Mallard, PhD, APRN-BC, FAAN, FAANP, Dean and Professor, Kent State University College of Nursing, has been elected to serve on the Board of Directors. Dr. Johnson-Mallard was inducted into the Academy in 2014 and served on this year’s Policy Conference Planning Advisory Committee. The immediate past Chair of the Women’s Health Expert Panel and a Robert Wood Johnson Foundation Nurse Faculty Scholar alum, Dr. Johnson-Mallard is an expert in women’s as well as reproductive health and studies behavioral change in response to culturally-appropriate nursing interventions.

“My passion for excellence in nursing drives my contributions to the profession,” said Dr. Johnson-Mallard. “I will use my position on the Board of Directors to further policies that will improve the health of the patients we serve and the nurses we mentor.”

Margaret P. Moss, PhD, JD, RN, FAAN, Director, First Nations House of Learning and Associate Professor, University of British Columbia School of Nursing, has been elected to serve on the Board of Directors. Dr. Moss is the first and only American Indian to hold both nursing and juris doctorates, and published the first nursing textbook on American Indian health. She spoke on the panel Unseen Diversity: How to Elevate Inclusivity and Affect Change during the 2020 Institute for Nursing Leadership Critical Conversation on Health Equity and Racism. Dr. Moss was inducted into the Academy in 2008 and has previously served to advance the Academy’s diversity and inclusivity efforts.

“With 574 federally-recognized tribes in the US and hundreds more First Nations, Metis, and Inuit communities in Canada, it is imperative to acknowledge the breadth of backgrounds to provide culturally competent care,” said Dr. Moss. “I look forward to using my role on the Board to be an advocate for advancing equitable health policies especially for these continually unseen communities.”

Nancy S. Redeker, PhD, RN, FAHA, FAAN, Beatrice Renfield Term Professor of Nursing, Yale University School of Nursing, has been elected to serve on the Board of Directors. Dr. Redeker was inducted into the Academy in 2008 and is currently finishing her term as Chair of the Council for the Advancement of Nursing Science’s (CANS) National Advisory Council. Under her leadership, CANS, the Academy’s signature initiative focused on science, elevated its role as a formidable voice for nursing researchers in the biomedical community. Dr. Redeker is an internationally-acclaimed biobehavioral nurse scientist, focused on the role of sleep and sleep disorders among patients with acute and chronic conditions, and will be joining the University of Connecticut School of Nursing in March 2022.

“I am honored to be elected to continue my work within the Academy through the Board of Directors,” said Dr. Redeker. “I believe nursing science is the backbone to advancing health policy and I intend to utilize my lens as a scientist to advance the Academy’s mission.”

Continuing Board Members Include:

  • Angela F. Amar, PhD, RN, ANEF, FAAN, Dean and Professor at the University of Nevada, Las Vegas School of Nursing
  • Mary Magee Gullatte, PhD, RN, ANP-BC, AOCN, FAAN, Corporate Director of Nursing Innovation and Research, Emory Healthcare Network
  • Pamela R. Jeffries, PhD, RN, ANEF, FAAN, Dean, Vanderbilt University School of Nursing

This year’s election ballot also included positions for the Fellow Selection Committee and the Nominating Committee. The following individuals will join these committees at the conclusion of the policy conference.

Newly Elected Members of the Fellow Selection Committee:

  • Liam C. Hein, PhD, RN, FAAN, Associate Professor, University of South Carolina College of Nursing
  • Paula M. Meek, PhD, RN, ATSF, FAAN, Assistant Dean for PhD Program and Professor, University of Utah College of Nursing
  • Sheila Melander, PhD, ACNP-BC, FCCM, FAANP, FAAN, Associate Dean MSN, DNP, and Faculty Practice, University of Kentucky College of Nursing
  • Margaret C. Wilmoth, PhD, MSS, RN, FAAN, Major General, US Army (Retired), Executive Vice Dean, University of North Carolina Chapel Hill School of Nursing

Newly Elected Members of the Nominating Committee:

  • Nada Lukkahatai, PhD, MSN, RN, CNE, FAAN, Assistant Professor, Johns Hopkins University School of Nursing
  • David Marshall, JD, DNP, RN, FAONL, FAAN, Senior Vice President and Chief Nursing Executive, Cedars-Sinai
  • William E. Rosa, PhD, MBE, NP-BC, FAANP, FAAN, Chief Research Fellow, Memorial Sloan Kettering Cancer Center
Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modificatio. Analysis of 72 patients treated in STK-001 clinical trials suggests that higher STK-001 drug exposure in brain leads to greater seizure reductions. Two-year data from the longest prospective natural history study of Dravet syndrome showed that, on average, patients experienced no meaningful improvement in convulsive seizure frequency and exhibited widening gaps in cognition and behavior despite treatment with the best available anti-seizure medicines.
"Exact Sciences is looking forward to presenting new evidence at SABCS that adds important perspectives to treating breast cancer patients and showing that some patients may be able to de-escalate treatments and still have positive outcomes," said Dr. Rick Baehner, Chief Medical Officer, Precision Oncology, Exact Sciences. "Every year, we build upon the precedent set by the Oncotype DX Breast Recurrence Score® test and its prognostic and predictive abilities to determine the chemotherapy benefit for specific breast cancer patients. We are pleased to see authorities expanding access to this test as we continue to develop key evidence in collaboration with some of the world's most prestigious, breast cancer-focused organizations."
Clozapine has been established as the most effective antipsychotic medication for treatment-resistant schizophrenia. However, it is significantly underutilized mainly due to the risk of developing agranulocytosis and the need to frequently monitor the absolute neutrophil count (ANC).
Dagi-Ben Noon, CEO of Inspira Technologies, reflects on the partnership's significance: "By Integrating our technology to oxygenate blood directly with Ennocure's infection prevention solutions, we are focusing on potentially improving patient outcomes in ICUs and paving the way for safer, more effective life-support treatments. This collaboration is expected to accelerate the development and broaden the implementation of our advanced technology."
The findings suggest that the novel, non-invasive genomic test can help physicians guide next steps for these patients, enabling them to potentially avoid unnecessary invasive procedures or accelerate time to appropriate treatment.

By using this website you agree to accept Medical Device News Magazine Privacy Policy